Literature DB >> 16857742

Ras-dependent recruitment of c-Myc for transcriptional activation of nucleophosmin/B23 in highly malignant U1 bladder cancer cells.

Chun-Wei Yeh1, Sheng-Shun Huang, Ru-Ping Lee, Benjamin Yat-Ming Yung.   

Abstract

U1 bladder cancer cells of high malignancy exhibited higher proliferation capacity than U4 premalignant cells. Higher expression of Ras, c-Myc, and nucleophosmin/B23 and greater c-Myc transactivation and nucleophosmin/B23 promoter activities were detected in U1 cells compared with U4 cells. Moreover, c-Myc and nucleophosmin/B23 were increased in U1 but not in U4 cells upon serum stimulation from quiescence. Likewise, only in U1 cells could serum stimulate transcriptional activity of nucleophosmin/B23 promoter and c-Myc response element. The increase of nucleophosmin/B23 promoter activity could be abrogated by mitogen-activated protein kinase/extracellular signal-regulated kinase activating kinase inhibitor and was associated with recruitment of c-Myc to the promoter. U1 cells constitutively expressing dominant-negative Ras reduced the levels of Ras, nucleophosmin/B23, and p-ERK, and consequently abolished the serum-induced up-regulation of nucleophosmin/B23 promoter activity and c-Myc promoter recruitment. Our results indicate that Ras and c-Myc play important roles in the up-regulation of nucleophosmin/B23 during proliferation of cells associated with a high degree of malignancy, thus outlining a signaling cascade involving these factors in the cancer cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16857742     DOI: 10.1124/mol.106.024810

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  7 in total

1.  Increased nucleophosmin expression is a strong predictor of recurrence and prognosis in patients with N0M0 upper tract urothelial carcinoma undergoing radical nephroureterectomy.

Authors:  Harutake Sawazaki; Keiichi Ito; Takako Asano; Kenji Kuroda; Akinori Sato; Junichi Asakuma; Akio Horiguchi; Kenji Seguchi; Tomohiko Asano
Journal:  World J Urol       Date:  2016-11-24       Impact factor: 4.226

2.  Estrogen stimulates the proliferation of human endometrial cancer cells by stabilizing nucleophosmin/B23 (NPM/B23).

Authors:  Angel Chao; Chiao-Yun Lin; Chia-Lung Tsai; Swei Hsueh; Ying-Yu Lin; Cheng-Tao Lin; Hung-Hsueh Chou; Tzu-Hao Wang; Chyong-Huey Lai; Hsin-Shih Wang
Journal:  J Mol Med (Berl)       Date:  2012-08-29       Impact factor: 4.599

3.  Expression of nucleophosmin/NPM1 correlates with migration and invasiveness of colon cancer cells.

Authors:  Yan Liu; Fei Zhang; Xiao-Fang Zhang; Li-Sha Qi; Lei Yang; Hua Guo; Ning Zhang
Journal:  J Biomed Sci       Date:  2012-05-25       Impact factor: 8.410

4.  Nanotopographical control of stem cell differentiation.

Authors:  Laura E McNamara; Rebecca J McMurray; Manus J P Biggs; Fahsai Kantawong; Richard O C Oreffo; Matthew J Dalby
Journal:  J Tissue Eng       Date:  2010-08-18       Impact factor: 7.813

Review 5.  Association between the TACC3 rs798766 Polymorphism and Risk of Urinary Bladder Cancer: A Synthesis Based on Current Evidence.

Authors:  Xiang-Yu Meng; Ming-Jun Shi; Jia-Feng Chen; Yi Liao; Bang-Wang Hu; Ahmed Hireche
Journal:  Dis Markers       Date:  2017-06-05       Impact factor: 3.434

6.  Phosphorylation of signal transducer and activator of transcription 1 reduces bortezomib-mediated apoptosis in cancer cells.

Authors:  C Kao; A Chao; C L Tsai; C Y Lin; W C Chuang; H W Chen; T C Yen; T H Wang; C H Lai; H S Wang
Journal:  Cell Death Dis       Date:  2013-02-28       Impact factor: 8.469

7.  Implication of NPM1 phosphorylation and preclinical evaluation of the nucleoprotein antagonist N6L in prostate cancer.

Authors:  Damien Destouches; Maha Sader; Stéphane Terry; Charles Marchand; Pascale Maillé; Pascale Soyeux; Gilles Carpentier; Fannie Semprez; Jocelyn Céraline; Yves Allory; José Courty; Alexandre De La Taille; Francis Vacherot
Journal:  Oncotarget       Date:  2016-10-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.